Trial intelligence / Profile preview

Randomized Double-Blind Comparison of Arimidex vs Nolvadex as Neoadjuvant and Adjuvant Therapy in Postmenopausal Women With Hormone Receptor–Positive Large or Locally Advanced Breast Cancer

jRCT2080220266Phase 3

Sponsor

AstraZeneca

Start

Jun 2006

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules

Countries

1